The ability of metformin to disrupt mitochondrial metabolism may help mitigate the risk of cancer in patients with Li-Fraumeni syndrome.
Payal Khincha, MBBS, MSHS
Advertisement
Articles by Payal Khincha, MBBS, MSHS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Clears IND Application for Novel IL-2 Agent in Advanced NSCLC
2
Lifileucel Confers Durable Responses in Pretreated Advanced NSCLC Type
3
EDIC Displays Continuous Evolution as Variable in EOT Grade 3 Lymphopenia
4
How Can Oncology Staffing Shortages Be Remedied?
5
